Skip to content
Next Wave (India)  logo —  A Pharmaceutical Company

Next Wave (India)

A Pharmaceutical Company

Founded 2006 India Paonta Sahib, India 64 employees Manufacturing, Pharmaceutical

General Information

Company Name Next Wave (India)
Founded Year 2006
Location India Paonta Sahib, India
Employees 64
Industries Manufacturing, Pharmaceutical
Social

BounceWatch is an independent company data service, not affiliated with Next Wave (India) . To contact Next Wave (India) , visit nextwaveindia.in.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Next Wave (India) compare?

A PDF of Next Wave (India) and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Next Wave (India) soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Next Wave (India)

Next Wave (India) is a pharmaceutical company founded in 2006 with a focus on supporting the medical fraternity by manufacturing quality medicines. The company's manufacturing facility is equipped to produce finished dosage forms of Tablets, Liquids, Capsules, and External Application. Notably, the facility holds accreditations including WHO-GMP and PIC/s-GMP certifications, while the company's laboratory has been awarded GLP certification. One of the key strengths of the company lies in its cGMP compliant Formulation Development Lab, which supports New Product Development. As of now, there is no publicly available information on its last investment or the investorsNext Wave (India) appears to have established a robust presence within the pharmaceutical industry in India through its dedication to producing quality medicines and maintaining high standards of manufacturing and laboratory processes.

Business keywords: Pharmaceutical Company, Quality Medicines, Finished Dosage Forms, Tablets, Liquids, Capsules, External Application, WHO-GMP Certification, PIC/s-GMP Certification, GLP Certification, cGMP Compliant Formulation Development Lab, Contract Manufacturing, Product Development Services, Cutting-edge Technology

No funding data available for Next Wave (India) yet.

Next Wave (India) Alternatives & Competitors

View All Alternatives
Next Wave (India) vs

Alpa Laboratories Limited, is a leading Pharmaceutical Manufacturing Company in India.

49 employees
Manufacturing, Pharmaceutical
Next Wave (India) vs

Third Party Pharmaceutical Manufacturer and Exporter (WHO GMP) - Tablets, Capsules, Dry & Liquid Syr...

21 employees
Manufacturing, Pharmaceutical
Next Wave (India) vs

Care , Cure with confidence

35 employees
Manufacturing, Pharmaceutical

FAQ About Next Wave (India)

A Pharmaceutical Company
Next Wave (India) was founded in 2006.
Next Wave (India) is headquartered in Paonta Sahib, India.
Next Wave (India) operates in Manufacturing and Pharmaceutical. Its work centres on Pharmaceutical Company, Quality Medicines, Finished Dosage Forms and Tablets.
Next Wave (India) has approximately 64 employees.
Top alternatives and competitors to Next Wave (India) include Alpa Laboratories limited, Tiruvision Medicare, RADICON LABORATORIES LTD., Delpharm, Arovea Formulation Pvt Ltd. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Next Wave (India) and Alpa Laboratories limited are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Next Wave (India) , https://bouncewatch.com/company/next-wave-india, updated 2 January 2025. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout